Financials data is unavailable for this security.
View more
Year on year Ono Pharmaceutical Co Ltd grew revenues 12.41% from 447.19bn to 502.67bn while net income improved 13.53% from 112.72bn to 127.98bn.
Gross margin | 74.69% |
---|---|
Net profit margin | 24.20% |
Operating margin | 29.84% |
Return on assets | 12.38% |
---|---|
Return on equity | 15.38% |
Return on investment | 15.14% |
More ▼
Cash flow in JPYView more
In 2024, Ono Pharmaceutical Co Ltd increased its cash reserves by 72.82%, or 70.01bn. The company earned 110.66bn from its operations for a Cash Flow Margin of 22.01%. In addition the company generated 48.08bn cash from investing, though they paid out 89.85bn more in financing than they received.
Cash flow per share | 292.38 |
---|---|
Price/Cash flow per share | 6.92 |
Book value per share | 1,726.26 |
---|---|
Tangible book value per share | 848.23 |
More ▼
Balance sheet in JPYView more
Current ratio | 1.53 |
---|---|
Quick ratio | 1.32 |
Total debt/total equity | 0.2006 |
---|---|
Total debt/total capital | 0.1661 |
More ▼
Growth rates in JPY
SmartText is unavailable
Div yield(5 year avg) | 2.23% |
---|---|
Div growth rate (5 year) | 12.20% |
Payout ratio (TTM) | 31.36% |
EPS growth(5 years) | 21.61 |
---|---|
EPS (TTM) vs TTM 1 year ago | 7.64 |
More ▼